Related Experiment Video
Updated: Dec 28, 2025

06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
13.1K
A Drosophila Model for Clostridium difficile Toxin CDT Reveals Interactions with Multiple Effector Pathways.
Ruth Schwartz1, Annabel Guichard2, Nathalie C Franc3
1Section of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA 92093-0335, USA.
Iscience
|February 15, 2020
Summary
Clostridium difficile toxin A (CDTa) disrupts gut function by targeting actin polymerization. Inhibiting calmodulin or Rab11 pathways shows potential for treating C. difficile infections (CDIs).
Area of Science:
- Molecular Biology
- Cell Biology
- Microbiology
Background:
- Clostridium difficile infections (CDIs) are a significant cause of infectious diarrhea.
- Hyper-virulent C. difficile strains produce toxin CDT, which disrupts the host cytoskeleton.
- CDT ADP-ribosylates actin monomers, inhibiting actin polymerization.
Purpose of the Study:
- To investigate the in vivo interaction of the CDTa catalytic subunit with host signaling pathways.
- To explore potential therapeutic targets for CDIs.
Main Methods:
- Creation of transgenic Drosophila melanogaster expressing the CDTa subunit in the midgut.
- Analysis of cellular phenotypes, including F-actin networks, brush borders, and intercellular junctions.
- Investigating the roles of Rab11, Crag (DENND4), Calmodulin (Cam), and the Cam/Calcineurin pathway.
Main Results:
- CDTa expression in Drosophila midgut caused reduced body weight, fecal output, and survival.
- CDTa induced F-actin collapse, brush border elimination, and junctional disruption.
- Rab11 redistribution was observed, and its suppression ameliorated CDTa phenotypes.
- Calmodulin was essential for CDTa activity, and its inhibition reduced CDTa-induced damage.
Conclusions:
- CDTa disrupts intestinal epithelial integrity and digestive function by targeting actin dynamics.
- The Rab11 and Calmodulin pathways are critical mediators of CDTa toxicity.
- Inhibition of the Calmodulin/Calcineurin pathway presents a potential therapeutic strategy for CDIs.

